NEA Management Company, LLC
Q1 2014 13F-HR Holdings
Net value change ($000)
-32,873
(-1.6%)
New positions
3
Sold out positions
4
Turnover %
12.6%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2013
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| CBIO | 140,032 | NEW |
| AVIDITY BIOSCIENCES INC | 36,483 | NEW |
| TREVENA INC | 29,960 | NEW |
| INTERMUNE INC | 25,130 | 127.2% |
| Clovis Oncology, Inc. | 20,518 | 14.9% |
| HYPERION THERAPEUTICS INC | 16,094 | 27.6% |
| SUPN | 14,910 | 18.6% |
| Epizyme, Inc. | 12,698 | 9.5% |
| T | 12,017 | 4.3% |
| FUSION-IO INC | 11,332 | 18.1% |
Top Reduces (Value $000, Stocks/ETFs)
| GRPN | -213,602 | -33.4% |
| CVENT INC | -48,853 | -18.4% |
| CHANNELADVISOR CORP | -48,285 | -69.7% |
| GLUU | -23,062 | -100.0% |
| CADENCE PHARMACEUTICALS INC R3 | -18,736 | -100.0% |
| SOLTA MEDICAL INC | -8,436 | -100.0% |
| EXEL | -5,716 | -42.2% |
| ZHONE TECHNOLOGIES INC NEW | -5,355 | -21.0% |
| Millennial Media Inc. | -2,879 | -4.8% |
| FOLD | -1,583 | -11.9% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|